NIKKEI 225
40,074.69 +443.63 (+1.12%) HANG SENG
17,769.14 +50.53 (+0.29%) CRUDE OIL
83.06 +0.25 (+0.30%) GOLD FUTURES
2,339.90 +6.50 (+0.28%) DOW
39,331.85 +162.33 (+0.41%) Bitcoin GBP
48,893.80 -649.17 (-1.31%)
SAVA Jan 2025 5.000 put
| Previous close | 1.7600 |
| Open | 1.6800 |
| Bid | 1.5500 |
| Ask | 1.9500 |
| Strike | 5.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.5600 - 1.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 217 |
- Yahoo Finance Video
Cassava forms committee after US probe, researcher fraud
Cassava Sciences (SAVA) is reportedly forming a committee to investigate two senior employees. This comes after a US probe into fraud and a Cassava researcher was indicted by a jury over alleged fabrication of Alzheimer's drug trial results. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
Barrons.comCassava Sciences Shares Plunge on Indictment Against Former Advisor
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
GlobeNewswireCassava Sciences Issues Statement on Former Science Advisor
AUSTIN, Texas, June 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), reported it has learned today that a federal grand jury returned an indictment charging Hoau-Yan Wang for allegedly defrauding the U.S. National Institutes of Health (NIH). Hoau-Yan Wang was a tenured medical professor at a public university’s medical school as well as a former paid science advisor to Cassava Sciences. According to public court documents, Dr. Wang engaged in illegal behavior to defraud the go
